Truqap (capivasertib)

pCPA File Number: 22853

Negotiation Status:

Active Negotiation

Indication(s):

Breast cancer, locally advanced or metastatic (HR-positive, HER2-negative)

Sponsor/Manufacturer:

AstraZeneca Canada Inc.

CDA-AMC Project Number:

PC0341-000

pCPA Engagement Letter Issued:

2024-11-15

Negotiation Process Concluded:

Not Applicable